Guardant Health Announces Board and Executive Changes
Ticker: GH · Form: 8-K · Filed: Sep 15, 2025 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $362,500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
TL;DR
Guardant Health shakes up its board and exec pay structure. Big changes coming?
AI Summary
Guardant Health, Inc. announced on September 12, 2025, changes in its board of directors and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. Specific details regarding the individuals involved and the exact nature of the compensation changes are outlined within the report.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can indicate internal shifts that may affect future performance and strategy.
Key Players & Entities
- Guardant Health, Inc. (company) — Registrant
- September 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3100 Hanover Street Palo Alto, California 94304 (address) — Principal executive offices
FAQ
Who are the specific directors or officers departing from Guardant Health?
The filing indicates the departure of certain officers and directors, but the specific names are detailed within the full report under Item 5.02.
What are the new compensatory arrangements for the officers?
The filing refers to updates in compensatory arrangements for certain officers, with specific details provided in the full document under Item 5.02.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 12, 2025.
What is the primary business of Guardant Health, Inc. according to the filing?
Guardant Health, Inc. is classified under SERVICES-MEDICAL LABORATORIES [8071].
What items are being reported in this Form 8-K?
This Form 8-K reports on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; and Financial Statements and Exhibits.
Filing Stats: 910 words · 4 min read · ~3 pages · Grade level 11.9 · Accepted 2025-09-15 16:11:12
Key Financial Figures
- $0.00001 — nge on which registered Common Stock, $0.00001 par value per share GH The Nasdaq Glo
- $362,500 — stock unit award, each with a value of $362,500 (collectively, the "Initial Awards"). E
Filing Documents
- gh-20250912.htm (8-K) — 33KB
- gh-9152025xexhibit991.htm (EX-99.1) — 10KB
- image_0.jpg (GRAPHIC) — 57KB
- 0001576280-25-000267.txt ( ) — 238KB
- gh-20250912.xsd (EX-101.SCH) — 2KB
- gh-20250912_lab.xml (EX-101.LAB) — 21KB
- gh-20250912_pre.xml (EX-101.PRE) — 12KB
- gh-20250912_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Guardant Health, Inc., dated September 15, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: September 15, 2025 By: /s/ John G. Saia John G. Saia Chief Legal Officer and Corporate Secretary